SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B1 - Prospectus [Rule 424(b)(1)]
SEC Accession No. 0001047469-09-008683
Filing Date
2009-10-01
Accepted
2009-10-01 12:28:41
Documents
4
Filing Date Changed
2009-10-01

Document Format Files

Seq Description Document Type Size
1 424B1 a2194769z424b1.htm 424B1 3341325
2 G966113.JPG g966113.jpg GRAPHIC 56470
3 G227407.JPG g227407.jpg GRAPHIC 46703
4 G411744.JPG g411744.jpg GRAPHIC 18555
  Complete submission text file 0001047469-09-008683.txt   3510892
Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Filer) CIK: 0001405197 (see all company filings)

IRS No.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-144941 | Film No.: 091097823
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1